{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:17:34Z","timestamp":1790842654773,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL148852"],"award-info":[{"award-number":["R01HL148852"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01GM122839"],"award-info":[{"award-number":["R01GM122839"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["F31GM140554"],"award-info":[{"award-number":["F31GM140554"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["1360-19"],"award-info":[{"award-number":["1360-19"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA013330"],"award-info":[{"award-number":["P30CA013330"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01HL069438"],"award-info":[{"award-number":["R01HL069438"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK98263"],"award-info":[{"award-number":["R01DK98263"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK115577"],"award-info":[{"award-number":["R01DK115577"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007319","name":"Albert Einstein College of Medicine, Yeshiva University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.exphem.2023.05.004","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T20:36:51Z","timestamp":1684787811000},"page":"45-55.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Comparative analysis of Tet2 catalytic-deficient and knockout bone marrow over time"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6075-5064","authenticated-orcid":false,"given":"Julio C.","family":"Flores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3358-0064","authenticated-orcid":false,"given":"Cheng-Yen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2997-084X","authenticated-orcid":false,"given":"Qin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3608-1914","authenticated-orcid":false,"given":"Chie","family":"Yanase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3121-2500","authenticated-orcid":false,"given":"Meelad M.","family":"Dawlaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2023.05.004_bib0001","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","article-title":"Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1","volume":"324","author":"Tahiliani","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.exphem.2023.05.004_bib0002","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1126\/science.1210597","article-title":"Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine","volume":"333","author":"Ito","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.exphem.2023.05.004_bib0003","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1126\/science.1210944","article-title":"Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA","volume":"333","author":"He","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.exphem.2023.05.004_bib0004","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrm3589","article-title":"TETonic shift: biological roles of TET proteins in DNA demethylation and transcription","volume":"14","author":"Pastor","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.exphem.2023.05.004_bib0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nrm2950","article-title":"Active DNA demethylation: many roads lead to Rome","volume":"11","author":"Wu","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.exphem.2023.05.004_bib0006","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature10066","article-title":"TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity","volume":"473","author":"Williams","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2023.05.004_bib0007","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature09934","article-title":"Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells","volume":"473","author":"Wu","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2023.05.004_bib0008","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3390\/cells11081366","article-title":"Tet1 suppresses p21 to ensure proper cell cycle progression in embryonic stem cells","volume":"11","author":"Chrysanthou","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.exphem.2023.05.004_bib0009","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1093\/nar\/gkac089","article-title":"The DNA dioxygenase Tet1 regulates H3K27 modification and embryonic stem cell biology independent of its catalytic activity","volume":"50","author":"Chrysanthou","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2023.05.004_bib0010","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature11742","article-title":"TET2 promotes histone O-GlcNAcylation during gene transcription","volume":"493","author":"Chen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2023.05.004_bib0011","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/emboj.2012.357","article-title":"TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1\/COMPASS","volume":"32","author":"Deplus","year":"2013","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2023.05.004_bib0012","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","article-title":"Mutation in TET2 in myeloid cancers","volume":"360","author":"Delhommeau","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2023.05.004_bib0013","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/leu.2009.59","article-title":"Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS\/MPN and AML","volume":"23","author":"Tefferi","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2023.05.004_bib0014","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/leu.2009.47","article-title":"TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis","volume":"23","author":"Tefferi","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2023.05.004_bib0015","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1182\/blood-2009-03-210039","article-title":"Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies","volume":"114","author":"Abdel-Wahab","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2023.05.004_bib0016","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.391","article-title":"Acquired mutations in TET2 are common in myelodysplastic syndromes","volume":"41","author":"Langemeijer","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2023.05.004_bib0017","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3324\/haematol.2009.011205","article-title":"TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia","volume":"94","author":"Kosmider","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2023.05.004_bib0018","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.stem.2013.06.003","article-title":"The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation","volume":"13","author":"Song","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2023.05.004_bib0019","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2011.06.001","article-title":"Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation","volume":"20","author":"Moran-Crusio","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2023.05.004_bib0020","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1182\/blood-2010-12-325241","article-title":"Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies","volume":"118","author":"Li","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2023.05.004_bib0021","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3324\/haematol.2013.088740","article-title":"Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma","volume":"98","author":"Asmar","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2023.05.004_bib0022","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1158\/2159-8290.CD-18-0657","article-title":"TET2 deficiency causes germinal center hyperplasia, impairs plasma cell differentiation, and promotes B-cell lymphomagenesis","volume":"8","author":"Dominguez","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.exphem.2023.05.004_bib0023","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","volume":"120","author":"Lemonnier","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2023.05.004_bib0024","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/bloodadvances.2017014118","article-title":"B-cell tumor development in Tet2-deficient mice","volume":"2","author":"Mouly","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2023.05.004_bib0025","doi-asserted-by":"crossref","first-page":"15102","DOI":"10.1038\/ncomms15102","article-title":"Tet2 loss leads to hypermutagenicity in haematopoietic stem\/progenitor cells","volume":"8","author":"Pan","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2023.05.004_bib0026","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":"TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis","volume":"20","author":"Quivoron","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2023.05.004_bib0027","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2023.05.004_bib0028","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ccell.2023.01.003","article-title":"IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment","volume":"41","author":"Leca","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2023.05.004_bib0029","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1016\/j.celrep.2019.07.094","article-title":"Non-catalytic roles of Tet2 are essential to regulate hematopoietic stem and progenitor cell homeostasis","volume":"28","author":"Ito","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2023.05.004_bib0030","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aaf5530","article-title":"Self-renewal of a purified Tie2+ hematopoietic stem cell population relies on mitochondrial clearance","volume":"354","author":"Ito","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.exphem.2023.05.004_bib0031","doi-asserted-by":"crossref","first-page":"e54262","DOI":"10.15252\/embr.202154262","article-title":"NPM1 ablation induces HSC aging and inflammation to develop myelodysplastic syndrome exacerbated by p53 loss","volume":"23","author":"Morganti","year":"2022","journal-title":"EMBO Rep"},{"key":"10.1016\/j.exphem.2023.05.004_bib0032","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1101\/gr.239277.118","article-title":"TET2 binding to enhancers facilitates transcription factor recruitment in hematopoietic cells","volume":"29","author":"Rasmussen","year":"2019","journal-title":"Genome Res"},{"key":"10.1016\/j.exphem.2023.05.004_bib0033","doi-asserted-by":"crossref","first-page":"IJH34","DOI":"10.2217\/ijh-2021-0002","article-title":"Gene mutation spectrum of patients with myelodysplastic syndrome and progression to acute myeloid leukemia","volume":"10","author":"Liu","year":"2021","journal-title":"Int J Hematol Oncol"},{"key":"10.1016\/j.exphem.2023.05.004_bib0034","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1073\/pnas.1000834107","article-title":"Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion","volume":"107","author":"Beerman","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2023.05.004_bib0035","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/bfgp\/elv059","article-title":"Noncoding RNAs and their functional involvement in regulation of chronic myeloid leukemia","volume":"15","author":"Wang","year":"2016","journal-title":"Brief Funct Genomics"},{"key":"10.1016\/j.exphem.2023.05.004_bib0036","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40778-016-0057-1","article-title":"MicroRNAs in control of stem cells in normal and malignant hematopoiesis","volume":"2","author":"Roden","year":"2016","journal-title":"Curr Stem Cell Rep"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X23002278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X23002278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T21:27:53Z","timestamp":1778534873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X23002278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":36,"alternative-id":["S0301472X23002278"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2023.05.004","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of Tet2 catalytic-deficient and knockout bone marrow over time","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2023.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}